Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 614

1.

Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.

Richards DA.

J Clin Gastroenterol. 1983;5 Suppl 1:81-90. Review.

PMID:
6317740
2.

The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.

Powell JR, Donn KH.

J Clin Gastroenterol. 1983;5 Suppl 1:95-113. Review.

PMID:
6140286
4.

Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.

Katz LB, Scott CK, Shriver DA.

J Pharmacol Exp Ther. 1986 May;237(2):404-10.

PMID:
2871172
5.

Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.

Helman CA, Tim LO.

Pharmacotherapy. 1983 Jul-Aug;3(4):185-92.

PMID:
6136952
6.

Ranitidine: a new H2-receptor antagonist.

Berner BD, Conner CS, Sawyer DR, Siepler JK.

Clin Pharm. 1982 Nov-Dec;1(6):499-509. Review.

PMID:
6309467
7.

Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.

Gledhill T, Howard OM, Buck M, Paul A, Hunt RH.

Gut. 1983 Oct;24(10):904-8.

8.
9.

Effect of cimetidine and ranitidine on cardiovascular drugs.

Baciewicz AM, Baciewicz FA Jr.

Am Heart J. 1989 Jul;118(1):144-54. Review.

PMID:
2662728
10.
11.

Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.

Holloway RH, Kuljian B, Eshelman F, McCallum RW.

Clin Pharmacol Ther. 1984 Feb;35(2):203-7.

PMID:
6319068
12.

Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.

Smout AJ, Jonkman JH, Peeters PA, De Bruin H.

Aliment Pharmacol Ther. 1995 Feb;9(1):51-6.

PMID:
7766744
13.

Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.

Bruley des Varannes S, Duquesnoy C, Mamet JP, Slama A, Galmiche JP, Scarpignato C.

Aliment Pharmacol Ther. 1998 Nov;12(11):1155-61.

14.

The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.

Walt RP, Malé PJ, Hunt RH, Rawlings J, Milton-Thompson GJ, Misiewicz JJ.

Scand J Gastroenterol Suppl. 1981 Jun;69:33-7.

PMID:
6119780
15.

[Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data].

Simon B, Dammann HG, Müller P, Kather H.

Minerva Med. 1981 Oct 20;72(40):2657-61. Italian.

PMID:
6117040
16.

Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.

Grimley CE, Constantinides S, Snell CC, Mills JG, Nwokolo CU.

Aliment Pharmacol Ther. 1997 Oct;11(5):875-9.

17.

Comparison of famotidine with cimetidine and ranitidine.

Berardi RR, Tankanow RM, Nostrant TT.

Clin Pharm. 1988 Apr;7(4):271-84. Review.

PMID:
2896559
18.

Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.

Konturek SJ, Obtułowicz W, Kwiecień N, Kopp B, Oleksy J.

Scand J Gastroenterol Suppl. 1981 Jun;69:91-9.

PMID:
6119789
19.

Clinical comparison of cimetidine and ranitidine.

Brater DC, Peters MN, Eshelman FN, Richardson CT.

Clin Pharmacol Ther. 1982 Oct;32(4):484-9.

PMID:
6288312
20.

Supplemental Content

Support Center